The challenges include funding ,scientific complexities in vaccine development and ensuring that the distribution of vaccine is available

Which of the following is the biggest hurdle to overcome in creating a vaccine for COVID-19?Scientists are unsure what vaccine process to follow.The virus has not been sequenced.This is the first coronavirus to cause problems in humans.Scientists in China have sequenced the virus but w

The purpose of vaccine forecasting is

What is the advantage of developing a vaccine against one of the priority, potential pandemic agents to phase I stage in preparing for a future pandemic with disease X?1 pointPhase I clinical trials can provide early information about the safety and tolerability of the vaccine in humans, allowing for modifications or adjustments to the vaccine if neededPhase I clinical trials can provide information about the spread and epidemiology of disease X in the human population, allowing for targeted vaccination strategiesPhase I clinical trials can provide a more cost-effective approach to vaccine development than later-stage clinical trials, saving resources in pandemic preparedness efforts.Phase I clinical trials can provide a clear understanding of the effectiveness of the vaccine in preventing disease X, allowing for large-scale manufacturing and distribution of the vaccine5.Question 5What is the main advantage of flexi

Using your knowledge of the third line of defence, explain why a different vaccine needs to be developed for each infectious disease.

In 2020, scientists are working across the globe to quickly create a safe and effective vaccine to protect individuals against COVID-19. The creation of a safe vaccine is a long process with many steps. The fastest vaccine ever created took about 4 years to make.Flu shot by Military Health System (CC0)As scientists are working to make a vaccine against COVID-19, which of the following do they need to take into consideration?Elimination ToolSelect one answerAThe number of people infected with COVID-19.BThe number of people infected with other viruses.CThe safety of the vaccine when injected into a human patient.DThe amount that each vaccine will cost.